首页> 外文期刊>European journal of medical research. >Mixed epithelial and mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast: a case report
【24h】

Mixed epithelial and mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast: a case report

机译:乳腺混合上皮和间质化生癌(癌肉瘤):一例

获取原文
           

摘要

Metaplastic breast carcinoma (MBC) is an uncommon malignancy characterized by the co-existence of two or more cellular types, commonly a mixture of epithelial and mesenchymal components. A case of a female patient aged 46 years with MBC (carcinosarcoma) is presented, including mammographic, ultrasonic, gross examination, and pathological findings. After undergoing modified radical mastectomy of the left breast and subsequent six courses of adjuvant chemotherapy and endocrine therapy, the patient is now doing well with no recurrence and metastasis. Conventional treatments for invasive ductal carcinoma (IDC) may appear to be less effective. Patients with MBC would be appropriate candidates for innovative or targeted therapy regimens.Keywords: metaplastic breast cancer, carcinosarcoma, treatment, progonosis
机译:化生性乳腺癌(MBC)是一种罕见的恶性肿瘤,其特征是两种或多种细胞类型(通常是上皮和间质成分的混合物)并存。介绍了一名女性患者,年龄为46岁,患有MBC(癌肉瘤),包括乳房X线照片,超声检查,大体检查和病理结果。在对左乳房进行改良的根治性乳房切除术并随后进行了六个疗程的辅助化学疗法和内分泌治疗之后,患者现在状况良好,没有复发和转移。浸润性导管癌(IDC)的常规治疗似乎无效。 MBC患者将是创新或靶向治疗方案的合适候选人。关键词:化生性乳腺癌,癌肉瘤,治疗,前凸

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号